Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
9.03
-0.28 (-2.96%)
At close: Jun 27, 2025, 4:00 PM
9.13
+0.11 (1.16%)
After-hours: Jun 27, 2025, 7:12 PM EDT

Syndax Pharmaceuticals Statistics

Total Valuation

SNDX has a market cap or net worth of $776.58 million. The enterprise value is $605.90 million.

Market Cap 776.58M
Enterprise Value 605.90M

Important Dates

The next estimated earnings date is Thursday, July 31, 2025, after market close.

Earnings Date Jul 31, 2025
Ex-Dividend Date n/a

Share Statistics

SNDX has 86.05 million shares outstanding. The number of shares has increased by 15.54% in one year.

Current Share Class 86.05M
Shares Outstanding 86.05M
Shares Change (YoY) +15.54%
Shares Change (QoQ) +0.44%
Owned by Insiders (%) 0.67%
Owned by Institutions (%) 108.29%
Float 76.95M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 19.03
Forward PS 5.19
PB Ratio 3.88
P/TBV Ratio 3.61
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 13.86
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.80, with a Debt / Equity ratio of 1.61.

Current Ratio 5.80
Quick Ratio 5.69
Debt / Equity 1.61
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -26.59

Financial Efficiency

Return on equity (ROE) is -93.70% and return on invested capital (ROIC) is -40.76%.

Return on Equity (ROE) -93.70%
Return on Assets (ROA) -36.29%
Return on Invested Capital (ROIC) -40.76%
Return on Capital Employed (ROCE) -62.92%
Revenue Per Employee $161,933
Profits Per Employee -$1.23M
Employee Count 270
Asset Turnover 0.07
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -54.60% in the last 52 weeks. The beta is 0.74, so SNDX's price volatility has been lower than the market average.

Beta (5Y) 0.74
52-Week Price Change -54.60%
50-Day Moving Average 10.94
200-Day Moving Average 14.45
Relative Strength Index (RSI) 36.22
Average Volume (20 Days) 1,837,781

Short Selling Information

The latest short interest is 22.00 million, so 25.57% of the outstanding shares have been sold short.

Short Interest 22.00M
Short Previous Month 23.14M
Short % of Shares Out 25.57%
Short % of Float 28.59%
Short Ratio (days to cover) 9.96

Income Statement

In the last 12 months, SNDX had revenue of $43.72 million and -$331.20 million in losses. Loss per share was -$3.86.

Revenue 43.72M
Gross Profit -199.64M
Operating Income -343.67M
Pretax Income -264.08M
Net Income -331.20M
EBITDA -343.66M
EBIT -343.67M
Loss Per Share -$3.86
Full Income Statement

Balance Sheet

The company has $516.31 million in cash and $345.63 million in debt, giving a net cash position of $170.68 million or $1.98 per share.

Cash & Cash Equivalents 516.31M
Total Debt 345.63M
Net Cash 170.68M
Net Cash Per Share $1.98
Equity (Book Value) 215.06M
Book Value Per Share 2.50
Working Capital 454.20M
Full Balance Sheet

Cash Flow

Operating Cash Flow -286.52M
Capital Expenditures n/a
Free Cash Flow -286.52M
FCF Per Share -$3.33
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -786.03%
Pretax Margin -757.52%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SNDX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -15.54%
Shareholder Yield -15.54%
Earnings Yield -42.65%
FCF Yield -36.89%
Dividend Details

Analyst Forecast

The average price target for SNDX is $35.91, which is 297.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target $35.91
Price Target Difference 297.90%
Analyst Consensus Strong Buy
Analyst Count 11
Revenue Growth Forecast (5Y) 93.93%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

SNDX has an Altman Z-Score of -1.51 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.51
Piotroski F-Score 1